Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays
Nucleic Acids Research · 2023
DOI: 10.1093/nar/gkad981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2023. Verfasst von Kamyar Yazdani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Chemical Biology Laboratory, National Cancer Institute, 1050 Boyle St., Frederick, MD 21702, USA. Hauptthemen laut MEDLINE: DNA, Nucleotide Motifs. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NCI NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
DNA i-motifs (iMs) are non-canonical C-rich secondary structures implicated in numerous cellular processes. Though iMs exist throughout the genome, our understanding of iM recognition by proteins or small molecules is limited to a few examples. We designed a DNA microarray containing 10976 genomic iM sequences to examine the binding profiles of four iM-binding proteins, mitoxantrone and the iMab antibody. iMab microarray screens demonstrated that pH 6.5, 5% BSA buffer was optimal, and fluorescence was correlated with iM C-tract length. hnRNP K broadly recognizes diverse iM sequences, favoring 3–5 cytosine repeats flanked by thymine-rich loops of 1–3 nucleotides. Array binding mirrored public ChIP-Seq datasets, in which 35% of well-bound array iMs are enriched in hnRNP K peaks. In contrast, other reported iM-binding proteins had weaker binding or preferred G-quadruplex (G4) sequences instead. Mitoxantrone broadly binds both shorter iMs and G4s, consistent with an intercalation mechanism. These results suggest that hnRNP K may play a role in iM-mediated regulation of gene expression in vivo, whereas hnRNP A1 and ASF/SF2 are possibly more selective in their binding preferences. This powerful approach represents the most comprehensive investigation of how biomolecules selectively recognize genomic iMs to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Chemical Biology Laboratory, National Cancer Institute, 1050 Boyle St., Frederick, MD 21702, USA.
- Genome Analysis Unit, National Cancer Institute, 37 Convent Dr., Bethesda, MD 20892, USA.
- Laboratory of Metabolism, National Cancer Institute, 37 Convent Dr., Bethesda, MD 20892, USA.
ORCID-Profile: Desiree Tillo, John S Schneekloth
Förderung
- NIH HHS
- NCI NIH HHS
- National Institutes of Health
- National Cancer Institute
Zitieren
APA
Yazdani, K., Seshadri, S., Tillo, D., Yang, M., Sibley, C. D., Vinson, C., & Schneekloth, J. S. (2023). Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays. Nucleic Acids Research. https://doi.org/10.1093/nar/gkad981
Vancouver
Yazdani K, Seshadri S, Tillo D, Yang M, Sibley CD, Vinson C, et al. Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays. Nucleic Acids Research. 2023. doi:10.1093/nar/gkad981
BibTeX
@article{Yazdani2023,
author = {Yazdani, Kamyar and Seshadri, Srinath and Tillo, Desiree and Yang, Mo and Sibley, Christopher D and Vinson, Charles and Schneekloth, John S},
title = {Decoding complexity in biomolecular recognition of DNA i-motifs with microarrays},
journal = {Nucleic Acids Research},
year = {2023},
doi = {10.1093/nar/gkad981}
}
EUVIMED